Michael Dugan
Hematology & Oncology · Indianapolis, INNPI 1437263399
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $182,973 of the $236,221 with a category attached, or 77.5%. 17 manufacturers reported payments, led by Bristol Myers Squibb at 52.9% of the total. Reporting peaked in 2019 at $73,886 and has fallen 99.9% since, to $52 in 2025. Among hematology & oncology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $905.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$125K
- E.r. Squibb & Sons, L.L.C.$91K
- Jazz Pharmaceuticals Inc.$10K
- Pfizer$4K
- Johnson & Johnson$3K
- Adaptive Biotechnologies Corporation$2K
- plus $714 from 11 others
What the payments were for
- Consulting fees$14,8526%
- Speaking & faculty fees$182,97377%
- Travel & lodging$33,05114%
- Food & beverage$5,3122%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 120 | $124,944 |
| E.r. Squibb & Sons, L.L.C. | 90 | $91,199 |
| Jazz Pharmaceuticals Inc. | 18 | $10,335 |
| Pfizer | 8 | $4,033 |
| Johnson & Johnson | 8 | $3,484 |
| Adaptive Biotechnologies Corporation | 2 | $1,511 |
| Janssen Scientific Affairs, LLC | 4 | $259 |
| Amgen | 2 | $138 |
| Astellas Pharma US Inc | 1 | $105 |
| Seagen Inc. | 1 | $46 |
| AstraZeneca | 1 | $35 |
| AbbVie | 1 | $27 |
| Stryker | 1 | $26 |
| Gilead | 1 | $24 |
| Novartis | 1 | $22 |
| Sanofi | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$236,221 in reported general payments places this provider in the 95th percentile of 224 hematology & oncology providers in Indiana.
Other hematology & oncology in Indianapolis
- Richard GaynorIndianapolis$3.7M
- Ruemu BirhirayIndianapolis$3.1M
- Anand TandraIndianapolis$280K
- Attaya SuvannasankhaIndianapolis$253K
- Daniel MiltonIndianapolis$231K
- Amro ElshouryIndianapolis$212K
- Brian MulherinIndianapolis$175K
- Muhammad Sarfraz NawazIndianapolis$172K
- John EdwardsIndianapolis$169K
- Karam Al-IssaIndianapolis$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.